AKT1 and metabolic disease: Similarly, studies on metabolic disorders, such as on the impact of microcystin-LR on liver lipid metabolism via the PI3K/AKT/mTOR/SREBP1 signalling pathway, demonstrate the critical role of oxidative stress and lipid regulation in pathological conditions (Chu et al., 2022).